Performance of Novel Bed Side Scores as Predictors of Hospital Outcome in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Among Women; Cohort Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

203 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-07-31

Study Completion Date

2025-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

* Assess predictors of mortality in COPD exacerbation between men and women.
* Evaluate the clinical outcomes in acute exacerbation of COPD in women.
* Evaluate the validity of new scoring systems ( NIVO, DECAF, HACOR ) as a predictor for hospital outcome in acute exacerbation of COPD.
* Compare these new scoring system with the most widely used APACHE IV.
* Assessment of serum level of granulocyte colony stimulating factor ( GM-CSF) in detecting the severity of COPD exacerbation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Predictors of Hospital Readmission for Chronic Obstructive Pulmonary Disease Patients

NCT06348966

Hospital Radmission for COPD Patients

NOT_YET_RECRUITING

Predicting Risk Factors for Exacerbation of Chronic Obstructive Pulmonary Disease

NCT03450603

Chronic Obstructive Pulmonary Disease

RECRUITING

Monitoring of the End-tidal Carbon Dioxide (EtCO2) as a Severity Criterion in COPD Exacerbations

NCT05704881

Pulmonary Disease, Chronic Obstructive Exacerbation Copd

RECRUITING

Predictors of Acute Exacerbation in Patients With COPD - an Observational Study

NCT04140097

Chronic Obstructive Pulmonary Disease COPD COPD Exacerbation +1 more

ACTIVE_NOT_RECRUITING

Assessment of Updated Evaluation Scores in Critically ILL COPD Patients Admitted to Assiut University Hospital

NCT02259439

Chronic Obstructive Pulmonary Disease

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COPD Exacerbation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Female COPD

No interventions assigned to this group

Male COPD

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with AECOPD leading to hypoxemia, hypercapnia and respiratory acidosis with pH \< 7.35 and PaCO2 \> 45 mm of Hg will be admitted to the respiratory intensive care unit (ICU) for NIV or the ward will be eligible for inclusion and not in need for mechanical ventilation

Exclusion Criteria

* Requirement for emergency intubation.
* Other contraindications to NIPPV including cardiac or respiratory arrest; nonrespiratory organ failure (eg, severe encephalopathy, severe gastrointestinal bleeding, hemodynamic instability with or without unstable cardiac angina); facial surgery or trauma; upper-airway obstruction; inability to protect the airway and/or high risk of aspiration; and inability to clear secretions.(6)
* Age \< 35 years.

Minimum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No